Feng et al. posit that understanding the molecular, mechanistic link between HNF4α and NKX2-1 could lead to new avenues—targeting lineage plasticity—for developing combinatorial therapies and diagnostic strategies in LUAD and other cancers. The gene discussed is HNF4A; the disease is cancer.